Du Pont (NYSE:DD) Rating Reaffirmed
RBC Capital Markets now has a $68.00 Estimated Target Price on the $58.04 billion market cap company or 2.67% upside potential. In a recent report shared with investors on 4 December, Du Pont (NYSE:DD) shares have had their Sector Perform Rating reiterated by investment advisers at RBC Capital Markets.
From a total of 18 analysts covering Du Pont (NYSE:DD) stock, 7 rate it a ”Buy”, 1 a “Sell”, and 14 a ”Hold”. This means that 32% of the ratings are positive. The highest target price is $77 while the lowest target price is $50. The mean of all analyst targets is $64.28 with a -5.87% below today’s ($66.23) stock price. Du Pont was the topic of 19 analyst reports since July 30, 2015 according to the firm StockzIntelligence Inc. Argus Research maintained shares on November 2 with “Buy” rating. Vetr upgraded shares to “Strong-Buy” rating and $53.77 target share price in a report from a September 21. S&P Research downgraded DD stock in a recent report from October 28 to “Sell” rating. Bernstein initiated the rating on September 11. Bernstein has a “Mkt Perform” rating and a $56 price target on shares. Finally, Citigroup upgraded the stock to “Buy” rating in a report issued on a September 22.
The stock closed the day at $66.23 during the previous session. It is down 10.55% since May 1, 2015 and is downtrending. It has underperformed by 7.77% the S&P500.
E. I. du Pont de Nemours and Company is a science and technology company. The company has a market cap of $58.04 billion. The Company’s subsidiaries and affiliates conduct manufacturing, seed production or selling activities and distribute products manufactured by the Company. It has 21.52 P/E ratio. The Company’s divisions include Agriculture, Electronics & Communications, Industrial Biosciences, Nutrition & Health, Performance Materials and Safety & Protection.
According to Zacks Investment Research, “E.I. DuPont de Nemours is involved in science and technology in a range of disciplines including high-performance materials, specialty chemicals, pharmaceuticals and biotechnology. The company operates globally through strategic business units. Within the strategic business units, businesses manufacture and sell a wide range of products to many different markets, including the transportation, textile, construction, automotive, agricultural and hybrid seeds, nutrition and health, pharmaceuticals, packaging and electronics markets.” Get a free copy of the Zacks research report on E I Du Pont De Nemours And Co (DD).